Sam Deshpande - Humana Chief Officer
| 0J6Z Stock | 297.08 0.88 0.30% |
Executive
Sam Deshpande is Chief Officer of Humana Inc
| Age | 59 |
| Address | Humana Building, Louisville, KY, United States, 40202 |
| Phone | 502 580 1000 |
| Web | https://www.humana.com |
Humana Management Efficiency
The company has return on total asset (ROA) of 0.0401 % which means that it generated a profit of $0.0401 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0784 %, meaning that it generated $0.0784 on every $100 dollars invested by stockholders. Humana's management efficiency ratios could be used to measure how well Humana manages its routine affairs as well as how well it operates its assets and liabilities. Net Tangible Assets is likely to gain to about 4.8 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 15.6 B in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| LLB LLM | Neometals | N/A | |
| Martin Harris | Jupiter Fund Management | N/A | |
| Paula Moore | Jupiter Fund Management | N/A | |
| Peter Wallis | Lendinvest PLC | N/A | |
| Michael Bourne | Albion Technology General | 65 | |
| Scott BCom | Neometals | N/A | |
| Stephen Mitchell | Jupiter Fund Management | N/A | |
| Matthew Tooth | Lendinvest PLC | 49 | |
| Christian Reiche | Neometals | N/A | |
| ACMA ACMA | Albion Technology General | 52 | |
| Mark Boyne | Neometals | N/A | |
| Alex Dee | Lendinvest PLC | N/A | |
| Darren EMBA | Neometals | 55 | |
| Amanda Virgilio | Neometals | N/A | |
| MBA MA | Albion Technology General | N/A | |
| Ruth Pearson | Lendinvest PLC | N/A | |
| Leigh Rimmer | Lendinvest PLC | N/A | |
| Carcie Rogers | Supermarket Income REIT | N/A | |
| Rob Abraham | Supermarket Income REIT | N/A | |
| Jeremy Mcmanus | Neometals | N/A | |
| Michael Tamlin | Neometals | N/A | |
Management Performance
| Return On Equity | 0.0784 | ||||
| Return On Asset | 0.0401 |
Humana Inc Leadership Team
Elected by the shareholders, the Humana's board of directors comprises two types of representatives: Humana inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Humana. The board's role is to monitor Humana's management team and ensure that shareholders' interests are well served. Humana's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Humana's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Ventura, Chief Officer | ||
| Vishal MD, Chief Officer | ||
| Bruce Broussard, Strategic Advisor | ||
| George II, President Medicaid | ||
| Timothy Huval, Chief Officer | ||
| Eric Tagliere, Senior CTO | ||
| Samir Deshpande, Chief Officer | ||
| James MBA, President COO | ||
| MD MBA, President CenterWell | ||
| Timothy Wheatley, Segment Retail | ||
| Amy Fry, Sr Communications | ||
| Susan Diamond, Chief Officer | ||
| JohnPaul Felter, Chief VP | ||
| Lisa Stoner, Vice Relations | ||
| PharmD PharmD, Chief Solutions | ||
| Sam Deshpande, Chief Officer |
Humana Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Humana a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0784 | ||||
| Return On Asset | 0.0401 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 24.91 B | ||||
| Shares Outstanding | 137.19 M | ||||
| Shares Owned By Insiders | 0.21 % | ||||
| Shares Owned By Institutions | 94.75 % | ||||
| Price To Sales | 0.36 X | ||||
| Revenue | 106.37 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Humana Stock Analysis
When running Humana's price analysis, check to measure Humana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana is operating at the current time. Most of Humana's value examination focuses on studying past and present price action to predict the probability of Humana's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humana's price. Additionally, you may evaluate how the addition of Humana to your portfolios can decrease your overall portfolio volatility.